Insider track record Other Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Tony Wood. Officer active across 1 company, notably GSK plc. Aggregated, 42 disclosures have been recorded. History available since 16 October 2023. The latest transaction was filed on 14 April 2026 (Vesting). Regulator: RNS (LSE). All data is accessible without signup.
Declarations 42 total
● Chief Scientific Officer · Executives · 14 Apr 2026 · GSK plc 965 shares @ £21.67 0.0000% mcap 0.2% of flow GB00BN7SWP63⌘ RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-9 ● Chief Scientific Officer · Executives · 9 Apr 2026 · GSK plc 0
GB00BN7SWP63⌘ RNS:66208821-3d67-43ba-837e-411f45d449f1-14 Ideal exit: 4 Jan 2027 (T+270) ● Chief Scientific Officer · Executives · 18 Feb 2026 · GSK plc 0
GB00BN7SWP63⌘ RNS:342d95ec-4ba6-48b0-a108-3953a4b5fc9c ● Chief Scientific Officer · Executives · 13 Feb 2026 · GSK plc 219,851 shares 0
GB00BN7SWP63⌘ RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-24 ● Chief Scientific Officer · Executives · 13 Feb 2026 · GSK plc 103,330 shares @ £21.6002 19.5% of flow GB00BN7SWP63⌘ RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-25 ● Chief Scientific Officer · Executives · 12 Feb 2026 · GSK plc 25,915 shares @ £21.50 4.9% of flow GB00BN7SWP63⌘ RNS:6207777f-2477-470b-868f-21f92714189a-9 ● Chief Scientific Officer · Executives · 12 Feb 2026 · GSK plc 247,138 shares @ £21.50 46.4% of flow GB00BN7SWP63⌘ RNS:586c5c74-54b9-425a-a37c-ba21836ecce7-13 ● Chief Scientific Officer · Executives · 9 Feb 2026 · GSK plc 21,176 shares 0
GB00BN7SWP63⌘ RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-16 ● Chief Scientific Officer · Executives · 9 Feb 2026 · GSK plc 9,978 shares @ £22.1186 1.9% of flow GB00BN7SWP63⌘ RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-17 ● Chief Scientific Officer · Executives · 8 Jan 2026 · GSK plc 0
GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-21 Ideal exit: 5 Oct 2026 (T+270) ● Chief Scientific Officer · Executives · 9 Jan 2026 · GSK plc 934 shares @ £18.91 0.2% of flow GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-33 ● Chief Scientific Officer · Executives · 10 Oct 2025 · GSK plc 1,067 shares @ £16.40 0.6% of flow GB00BN7SWP63⌘ RNS:5862277-11 ● Chief Scientific Officer · Executives · 9 Oct 2025 · GSK plc 0
GB00BN7SWP63⌘ RNS:5859068-23 Ideal exit: 6 Jul 2026 (T+270) ● Chief Scientific Officer · Executives · 11 Jul 2025 · GSK plc 0
GB00BN7SWP63⌘ RNS:5739159-14 Ideal exit: 7 Apr 2026 (T+270) ● Chief Scientific Officer · Executives · 10 Jul 2025 · GSK plc 1,190 shares @ £14.545 0.6% of flow GB00BN7SWP63⌘ RNS:5737340-30 ● Chief Scientific Officer · Executives · 16 Apr 2025 · GSK plc 1,340 shares @ £12.75 0.6% of flow GB00BN7SWP63⌘ RNS:5622701-11 ● Chief Scientific Officer · Executives · 10 Apr 2025 · GSK plc 0
GB00BN7SWP63⌘ RNS:5617047-19 Ideal exit: 5 Jan 2026 (T+270) ● Chief Scientific Officer · Executives · 17 Feb 2025 · GSK plc 27,146 shares @ £14.35 13.3% of flow GB00BN7SWP63⌘ RNS:5546650-11 ● Chief Scientific Officer · Executives · 18 Feb 2025 · GSK plc 0
GB00BN7SWP63⌘ RNS:5546644 ● Chief Scientific Officer · Executives · 18 Feb 2025 · GSK plc 97,444 shares 0
GB00BN7SWP63⌘ RNS:5546637-19 ● Chief Scientific Officer · Executives · 18 Feb 2025 · GSK plc 45,799 shares @ £14.2531 22.4% of flow GB00BN7SWP63⌘ RNS:5546637-20 ● Chief Scientific Officer · Executives · 17 Feb 2025 · GSK plc 24,638 shares @ £14.1829 11.9% of flow GB00BN7SWP63⌘ RNS:5546608-0 ● Chief Scientific Officer · Executives · 17 Feb 2025 · GSK plc 11,580 shares GB00BN7SWP63⌘ RNS:5546608-1 ● Chief Scientific Officer · Executives · 14 Jan 2025 · GSK plc 877 shares @ £13.495 0.4% of flow GB00BN7SWP63⌘ RNS:5502203-12 ● Chief Scientific Officer · Executives · 9 Jan 2025 · GSK plc 0
GB00BN7SWP63⌘ RNS:5498728-11 Ideal exit: 6 Oct 2025 (T+270) 25 of 42 declarations
Load more (17 remaining) About Tony Wood Tony Wood is a declarant who has made 42 filings in total. In his most recent filings, he sold a total of 4047823 EUR between October 18, 2023, and April 16, 2026. Among his notable filings, he executed a sale on February 17, 2026, for an amount of 2560848.55 EUR and another on February 21, 2025, for 785689.76 EUR.